diallyl trisulfide has been researched along with Injury, Myocardial Reperfusion in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, X; Huang, J; Huang, K; Pang, L; Sun, X; Wang, F; Wang, Y; Wen, S | 1 |
| Cong, S; Ji, M; Liu, H; Lu, Y; Tao, H; Wang, W; Wang, X; Wei, L; Zhang, B; Zhao, Y | 1 |
| Aragon, JP; Bhushan, S; Condit, ME; Grinsfelder, DB; King, AL; Kondo, K; Lefer, DJ; Predmore, BL; Zlatopolsky, MA | 1 |
| Aili, L; Jiahui, L; Peng, Y; Xianlun, L; Yong, W; Yuannan, K; Zaixiang, S | 1 |
4 other study(ies) available for diallyl trisulfide and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Novel controlled and targeted releasing hydrogen sulfide system exerts combinational cerebral and myocardial protection after cardiac arrest.
Topics: Allyl Compounds; Animals; Antioxidants; Brain Ischemia; Cells, Cultured; Delayed-Action Preparations; Drug Delivery Systems; Heart Arrest; Hydrogen Sulfide; Magnetic Iron Oxide Nanoparticles; Male; Mice, Inbred BALB C; Myocardial Reperfusion Injury; Protective Agents; Rats, Sprague-Dawley; Sulfides | 2021 |
Controlled-releasing hydrogen sulfide donor based on dual-modal iron oxide nanoparticles protects myocardial tissue from ischemia-reperfusion injury.
Topics: Allyl Compounds; Animals; Cardiotonic Agents; Cell Line; Delayed-Action Preparations; Ferric Compounds; Heart; Homeostasis; Hydrogen Sulfide; Male; Mice; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nanoparticles; Sulfides | 2019 |
The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability.
Topics: Allyl Compounds; Animals; Antioxidants; Dose-Response Relationship, Drug; Hydrogen Sulfide; Male; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Models, Animal; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Sulfides; Ventricular Function, Left | 2012 |
Garlicin attenuates reperfusion no-reflow in a catheter-based porcine model of acute myocardial infarction.
Topics: Acute Disease; Allyl Compounds; Animals; Catheters; Disease Models, Animal; Disulfides; Echocardiography; Garlic; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Sulfides | 2012 |